Phase I trial of a first-in-class ATR inhibitor VX-970 as monotherapy (mono) or in combination (combo) with carboplatin (CP) incorporating pharmacodynamics (PD) studies

Abstract only

Saved in:

Bibliographic Details
Published in	Journal of clinical oncology Vol. 34; no. 15_suppl; p. 2504
Main Authors	O'Carrigan, Brent, de Miguel Luken, Maria Jose, Papadatos-Pastos, Dionysios, Brown, Jessica, Tunariu, Nina, Perez Lopez, Raquel, Ganegoda, Mahesha, Riisnaes, Ruth, Figueiredo, Ines, Carreira, Suzanne, Hare, Brian, Yang, Fang, McDermott, Katherine, Penney, Marina S., Pollard, John, Lopez, Juanita Suzanne, Banerji, Udai, De Bono, Johann S., Fields, Scott Z., Yap, Timothy Anthony
Format	Journal Article
Language	English
Published	20.05.2016
Online Access	Get full text

Loading…